Interferon α-stimulated natural killer cells from patients with acute hepatitis C virus (HCV) infection recognize HCV-infected and uninfected hepatoma cells via DNAX accessory molecule-1.

BACKGROUND: Natural killer (NK) cells are an important component of the innate immune defense against viruses, including hepatitis C virus (HCV). The cell culture system using HCV-permissive Huh-7.5 cells make studies on interaction of NK cells and HCV-infected target cells possible. We used this s...

Full description

Bibliographic Details
Main Authors: Stegmann, K, Björkström, N, Ciesek, S, Lunemann, S, Jaroszewicz, J, Wiegand, J, Malinski, P, Dustin, L, Rice, C, Manns, M, Pietschmann, T, Cornberg, M, Ljunggren, H, Wedemeyer, H
Format: Journal article
Language:English
Published: 2012
_version_ 1826294245029314560
author Stegmann, K
Björkström, N
Ciesek, S
Lunemann, S
Jaroszewicz, J
Wiegand, J
Malinski, P
Dustin, L
Rice, C
Manns, M
Pietschmann, T
Cornberg, M
Ljunggren, H
Wedemeyer, H
author_facet Stegmann, K
Björkström, N
Ciesek, S
Lunemann, S
Jaroszewicz, J
Wiegand, J
Malinski, P
Dustin, L
Rice, C
Manns, M
Pietschmann, T
Cornberg, M
Ljunggren, H
Wedemeyer, H
author_sort Stegmann, K
collection OXFORD
description BACKGROUND: Natural killer (NK) cells are an important component of the innate immune defense against viruses, including hepatitis C virus (HCV). The cell culture system using HCV-permissive Huh-7.5 cells make studies on interaction of NK cells and HCV-infected target cells possible. We used this system to characterize interactions of HCV-infected Huh-7.5 cells and NK cells from healthy controls and patients with acute HCV infection. METHODS: IFNα- and IL-2 stimulated NK cells were cultured with HCV-infected hepatoma cells and subsequently analyzed (for degranulation and cytokine production) via multicolour flow cytometry. Luciferase assyas have been used to study inhibition of HCV replication. Further, PBMC from patients with acute hepatitis C as well as HCV-infected Huh7.5 cells have been analyzed via flow cytometry for expression of NK cell receptors and ligands, respectively. RESULTS: After interferon (IFN) α stimulation, NK cells from healthy controls and patients with acute hepatitis C efficiently recognized both HCV-infected and uninfected hepatoma cells. Subsequent dissection of receptor-ligand interaction revealed a dominant role for DNAM-1 and a complementary contribution of NKG2D for NK cell activation in this setting. Furthermore, IFN-α-stimulated NK cells effectively inhibited HCV replication in a DNAM-1-dependent manner. CONCLUSIONS: Human NK cells recognize HCV-infected hepatoma cells after IFN-α stimulation in a DNAM-1-dependent manner. Furthermore, interaction of IFN-α-stimulated NK cells with HCV-infected hepatoma cells efficiently reduced HCV replication. This study opens up future studies of NK cell interaction with HCV-infected hepatocytes to gain further insight into the pathogenesis of human HCV infection and the therapeutic effects of IFN-α.
first_indexed 2024-03-07T03:42:39Z
format Journal article
id oxford-uuid:be6e1ea8-2d9f-4581-9506-b659e48146ae
institution University of Oxford
language English
last_indexed 2024-03-07T03:42:39Z
publishDate 2012
record_format dspace
spelling oxford-uuid:be6e1ea8-2d9f-4581-9506-b659e48146ae2022-03-27T05:39:22ZInterferon α-stimulated natural killer cells from patients with acute hepatitis C virus (HCV) infection recognize HCV-infected and uninfected hepatoma cells via DNAX accessory molecule-1.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:be6e1ea8-2d9f-4581-9506-b659e48146aeEnglishSymplectic Elements at Oxford2012Stegmann, KBjörkström, NCiesek, SLunemann, SJaroszewicz, JWiegand, JMalinski, PDustin, LRice, CManns, MPietschmann, TCornberg, MLjunggren, HWedemeyer, H BACKGROUND: Natural killer (NK) cells are an important component of the innate immune defense against viruses, including hepatitis C virus (HCV). The cell culture system using HCV-permissive Huh-7.5 cells make studies on interaction of NK cells and HCV-infected target cells possible. We used this system to characterize interactions of HCV-infected Huh-7.5 cells and NK cells from healthy controls and patients with acute HCV infection. METHODS: IFNα- and IL-2 stimulated NK cells were cultured with HCV-infected hepatoma cells and subsequently analyzed (for degranulation and cytokine production) via multicolour flow cytometry. Luciferase assyas have been used to study inhibition of HCV replication. Further, PBMC from patients with acute hepatitis C as well as HCV-infected Huh7.5 cells have been analyzed via flow cytometry for expression of NK cell receptors and ligands, respectively. RESULTS: After interferon (IFN) α stimulation, NK cells from healthy controls and patients with acute hepatitis C efficiently recognized both HCV-infected and uninfected hepatoma cells. Subsequent dissection of receptor-ligand interaction revealed a dominant role for DNAM-1 and a complementary contribution of NKG2D for NK cell activation in this setting. Furthermore, IFN-α-stimulated NK cells effectively inhibited HCV replication in a DNAM-1-dependent manner. CONCLUSIONS: Human NK cells recognize HCV-infected hepatoma cells after IFN-α stimulation in a DNAM-1-dependent manner. Furthermore, interaction of IFN-α-stimulated NK cells with HCV-infected hepatoma cells efficiently reduced HCV replication. This study opens up future studies of NK cell interaction with HCV-infected hepatocytes to gain further insight into the pathogenesis of human HCV infection and the therapeutic effects of IFN-α.
spellingShingle Stegmann, K
Björkström, N
Ciesek, S
Lunemann, S
Jaroszewicz, J
Wiegand, J
Malinski, P
Dustin, L
Rice, C
Manns, M
Pietschmann, T
Cornberg, M
Ljunggren, H
Wedemeyer, H
Interferon α-stimulated natural killer cells from patients with acute hepatitis C virus (HCV) infection recognize HCV-infected and uninfected hepatoma cells via DNAX accessory molecule-1.
title Interferon α-stimulated natural killer cells from patients with acute hepatitis C virus (HCV) infection recognize HCV-infected and uninfected hepatoma cells via DNAX accessory molecule-1.
title_full Interferon α-stimulated natural killer cells from patients with acute hepatitis C virus (HCV) infection recognize HCV-infected and uninfected hepatoma cells via DNAX accessory molecule-1.
title_fullStr Interferon α-stimulated natural killer cells from patients with acute hepatitis C virus (HCV) infection recognize HCV-infected and uninfected hepatoma cells via DNAX accessory molecule-1.
title_full_unstemmed Interferon α-stimulated natural killer cells from patients with acute hepatitis C virus (HCV) infection recognize HCV-infected and uninfected hepatoma cells via DNAX accessory molecule-1.
title_short Interferon α-stimulated natural killer cells from patients with acute hepatitis C virus (HCV) infection recognize HCV-infected and uninfected hepatoma cells via DNAX accessory molecule-1.
title_sort interferon α stimulated natural killer cells from patients with acute hepatitis c virus hcv infection recognize hcv infected and uninfected hepatoma cells via dnax accessory molecule 1
work_keys_str_mv AT stegmannk interferonastimulatednaturalkillercellsfrompatientswithacutehepatitiscvirushcvinfectionrecognizehcvinfectedanduninfectedhepatomacellsviadnaxaccessorymolecule1
AT bjorkstromn interferonastimulatednaturalkillercellsfrompatientswithacutehepatitiscvirushcvinfectionrecognizehcvinfectedanduninfectedhepatomacellsviadnaxaccessorymolecule1
AT cieseks interferonastimulatednaturalkillercellsfrompatientswithacutehepatitiscvirushcvinfectionrecognizehcvinfectedanduninfectedhepatomacellsviadnaxaccessorymolecule1
AT lunemanns interferonastimulatednaturalkillercellsfrompatientswithacutehepatitiscvirushcvinfectionrecognizehcvinfectedanduninfectedhepatomacellsviadnaxaccessorymolecule1
AT jaroszewiczj interferonastimulatednaturalkillercellsfrompatientswithacutehepatitiscvirushcvinfectionrecognizehcvinfectedanduninfectedhepatomacellsviadnaxaccessorymolecule1
AT wiegandj interferonastimulatednaturalkillercellsfrompatientswithacutehepatitiscvirushcvinfectionrecognizehcvinfectedanduninfectedhepatomacellsviadnaxaccessorymolecule1
AT malinskip interferonastimulatednaturalkillercellsfrompatientswithacutehepatitiscvirushcvinfectionrecognizehcvinfectedanduninfectedhepatomacellsviadnaxaccessorymolecule1
AT dustinl interferonastimulatednaturalkillercellsfrompatientswithacutehepatitiscvirushcvinfectionrecognizehcvinfectedanduninfectedhepatomacellsviadnaxaccessorymolecule1
AT ricec interferonastimulatednaturalkillercellsfrompatientswithacutehepatitiscvirushcvinfectionrecognizehcvinfectedanduninfectedhepatomacellsviadnaxaccessorymolecule1
AT mannsm interferonastimulatednaturalkillercellsfrompatientswithacutehepatitiscvirushcvinfectionrecognizehcvinfectedanduninfectedhepatomacellsviadnaxaccessorymolecule1
AT pietschmannt interferonastimulatednaturalkillercellsfrompatientswithacutehepatitiscvirushcvinfectionrecognizehcvinfectedanduninfectedhepatomacellsviadnaxaccessorymolecule1
AT cornbergm interferonastimulatednaturalkillercellsfrompatientswithacutehepatitiscvirushcvinfectionrecognizehcvinfectedanduninfectedhepatomacellsviadnaxaccessorymolecule1
AT ljunggrenh interferonastimulatednaturalkillercellsfrompatientswithacutehepatitiscvirushcvinfectionrecognizehcvinfectedanduninfectedhepatomacellsviadnaxaccessorymolecule1
AT wedemeyerh interferonastimulatednaturalkillercellsfrompatientswithacutehepatitiscvirushcvinfectionrecognizehcvinfectedanduninfectedhepatomacellsviadnaxaccessorymolecule1